The Scientist

» drug development

Most Recent

image: FDA to Revamp Rare Disease Efforts

FDA to Revamp Rare Disease Efforts

By Bob Grant | September 12, 2011

The US government agency vows to improve the way it facilitates the development and approval of drugs for orphan diseases.

3 Comments

image: Detecting New Synthetic Drugs

Detecting New Synthetic Drugs

By Cristina Luiggi | September 1, 2011

Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.

0 Comments

image: Data-Mining for New Treatments

Data-Mining for New Treatments

By Jef Akst | August 18, 2011

A new database helps scientist predict new uses for existing drugs.

3 Comments

image: FDA's Biomarker and Device Advice

FDA's Biomarker and Device Advice

By Bob Grant | August 18, 2011

The US federal agency issues draft rules to guide medical device makers and those hoping to register biomarkers.

0 Comments

image: Facebook Forces Pharma to Show Comments

Facebook Forces Pharma to Show Comments

By Edyta Zielinska | August 17, 2011

The social media site enforces its rule that pages should allow social interaction through comments, even on drug company pages.

0 Comments

image: The Father of Trial Randomization Dies

The Father of Trial Randomization Dies

By Bob Grant | August 15, 2011

Statistician Paul Meier, who championed the random assignment of patients to treatment groups in clinical trials, changed the way the researchers test experimental drugs.

0 Comments

image: FDA Discusses Biosimilars

FDA Discusses Biosimilars

By Edyta Zielinska | August 8, 2011

The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.

3 Comments

image: Battling Malaria in Africa

Battling Malaria in Africa

By Jef Akst | August 1, 2011

When general practitioner John Lusingu returned to his native Tanzania to do research on malaria, he was met with a total lack of science infrastructure. 

0 Comments

image: CRO Fakes Research

CRO Fakes Research

By Jef Akst | July 28, 2011

FDA points its finger at an early-stage contract research organization for falsifying documents and manipulating samples.

0 Comments

image: Patents Expire for Big Name Drugs

Patents Expire for Big Name Drugs

By Jef Akst | July 25, 2011

As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.

6 Comments

Popular Now

  1. Stem Cell Vaccine Protects Mice From Cancer
  2. Love in the Scientific Literature
    News Analysis Love in the Scientific Literature

    There are countless ways for scientists to say, “I love you.” Naming a slime-mold beetle after your wife (and another after your ex-wife) is, apparently, one of them.  

  3. Nobel Prize–Winning Biologist Dies
  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS